Samsung Biologics Co., Ltd. (207940)
Market Closed
12 Jun, 06:30
KRX SM KRX SM Primary ₩
1,295,000. 00
+9,000
+0.6998%
₩
76.33T Market Cap
- P/E Ratio
- Div Yield
54,753 Volume
13,763 Eps
₩ 1,286,000
Previous Close Want to track 207940 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Samsung Biologics Co., Ltd. (207940) Statistics
Valuation metrics
Market Cap 76.33T
Enterprise value 62.7T
Trailing P/E (ttm) 32.99
Forward P/E -
PEG ratio 0.7
Price/Sales (ttm) 13.74
Price/Book (mrq) 7.82
Enterprise Value/Revenue 13.89
Enterprise Value/EBITDA 25.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 61.55K
Average volume (90 days) 51.04K
Price summary
52-Week low 1,228,000
52-Week high 1,987,000
Beta -
50-Day moving average 1,445,906.25
200-Day moving average 1,322,556.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.65:1
Last split Date 30 Oct 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.42%
Operating margin 0.42%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 97,660.42
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 40,615.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 35,042.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 1.7%
Book value per share (mrq) 171,341.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
